Hpv-positive Oropharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Hpv-positive Oropharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer [NA]
Clinical trial update for Quarterback 2b, a sequential therapy using reduced-dose chemoradiotherapy for locally advanced HPV-positive oropha…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer) [Phase 2]
This Phase 2 study is evaluating neoadjuvant immunoradiotherapy combining evorpacept with pembrolizumab for HPV-positive oropharyngeal cance…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer [Phase 2, Phase 3]
A trial update on de‑intensified radiation therapy with either cisplatin chemotherapy or nivolumab immunotherapy for early-stage HPV-positiv…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) [Phase 3]
PATHOS is a Phase 3 clinical trial evaluating post-operative adjuvant treatment for HPV-positive oropharyngeal cancer; the study is currentl…